Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT00029003 · COMPLETED

Trial details

NCT number: NCT00029003
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchoalveolar Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Start date: 2001-12-01
Primary completion: 2004-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.